UAE
UAE: 900 children part of study on Sinopharm vaccine
The UAE’s study about the effectiveness of Sinopharm Covid-19 vaccine in children aged 3 to 17 years has examined 900 kids. With this, the Department of Health – Abu Dhabi (DoH) has enrolled the targeted number of children for the study.
The Sinopharm immune bridge study followed the vaccine’s effectiveness in reducing the infection rate and severity of symptoms among children of different nationalities.
Once available, the study’s preliminary results will help support the planning process for the safe return of students to schools.
